Sickle cell disease (SCD), one of the most common monogenic disorders in the world, is caused by a mutation of hemoglobin (typically β6Glu > Val). When deoxygenated, sickle hemoglobin tends to polymerize within the red blood cells, causing their deformation and rigidity (sickling), with hemolysis and vascular obstruction leading to vaso-occlusive pain crisis. Vaso-occlusive crisis will be experienced by nearly all individuals with SCD during their lifetime. There is a complex network of associated cellular changes (e.g., cell adhesion, endothelial activation, ischemia-reperfusion, and hemolysis-driven scavenging of nitric oxide), leading to a multisystem vascular disease involving progressive chronic organ damage and acute complications that may require intensive care unit admission (Fig. 1). We herein review some tips to manage critically ill patients with SCD.